| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8214605 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 11 Pages |
Abstract
SHP-1/STAT3 signaling is critically associated with the radiosensitivity of HCC cells. Combination therapy with RT and the SHP-1 agonist, such as dovitinib, resulted in enhanced in vitro and in vivo anti-HCC effects.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Chao-Yuan MD, PhD, Wei-Tien PhD, Szu-Yuan MD, Chih-Ting MS, Min-Hsuan MS, Ming-Hsien Tsai, Chiung-Wen PhD, Chung-Wai PhD, Man-Hsin MD, Kuen-Feng MD, PhD,